Screener
Ligand Pharmaceuticals LGND Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The source filing: Ligand Pharmaceuticals’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000886163-26-000044
| Line item | Three months ended / June 30, 2026 | Three months ended / June 30, 2025 | Six months ended / June 30, 2026 | Six months ended / June 30, 2025 |
|---|---|---|---|---|
| Interest income | 7,298 | 1,621 | 13,953 | 3,392 |
| Interest expense | (1,748) | (1,153) | (3,495) | (2,020) |
| Other non-operating expense, net | 2,682 | 1,372 | 1,507 | (1,129) |
| Total non-operating income (expenses), net | 55,713 | 2,779 | 14,086 | (11,185) |
| Income (loss) before income taxes | 64,304 | 11,223 | 40,045 | (38,957) |
| Income tax (expense) benefit | (15,796) | (6,376) | (4,882) | 1,353 |
| Net income (loss) | $48,508 | $4,847 | $35,163 | $(37,604) |
| Basic net income (loss) per share | $2.42 | $0.25 | $1.76 | $(1.95) |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Ligand Pharmaceuticals's other income (expense)?
- Ligand Pharmaceuticals (LGND) reported other income (expense) of $55.71M in Q2 2026.
- How has Ligand Pharmaceuticals's other income (expense) changed year-over-year?
- Ligand Pharmaceuticals's other income (expense) increased by 1904.8% year-over-year, from $2.78M to $55.71M.
- What is the long-term trend for Ligand Pharmaceuticals's other income (expense)?
- Over 3 years (2021 to 2025), Ligand Pharmaceuticals's other income (expense) has grown at a 55.1% compound annual growth rate (CAGR), from -$31.65M to $117.96M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.
Ask your AI about Ligand Pharmaceuticals's other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude